Port Delivery System with Ranibizumab: Developing the First Global Surgery, Device, Drug Combination Product for AMD & DME

Time: 11:40 am
day: Day One

Details:

  • Reviewing of PDS technology and procedures
  • AMD Phase 3 clinical trial outcomes testing 6 month durability
  • Unique development aspects of a combination product

Speakers: